Entamoeba histolytica exploits the autophagy pathway in macrophages to trigger inflammation in disease pathogenesis.

Mucosal Immunology
Sharmin BegumKris Chadee

Abstract

The mechanism whereby Entamoeba histolytica (Eh) binding with macrophages at the intercellular junction triggers aggressive pro-inflammatory responses in disease pathogenesis is not well understood. The host intracellular protein degradation process autophagy and its regulatory proteins are involved in maintenance of cellular homeostasis and excessive inflammatory responses. In this study we unraveled how Eh hijacks the autophagy process in macrophages to dysregulate pro-inflammatory responses. Direct contact of live Eh with macrophages activated caspase-6 that induced rapid proteolytic degradation of the autophagy ATG16L1 protein complex independent of NLRP3 inflammasome and caspase-3/8 activation. Crohn's disease susceptible ATG16L1 T300A variant was highly susceptible to Eh-mediated degradation that augmented pro-inflammatory cytokines in mice. Quantitative proteomics revealed downregulation of autophagy and vesicle-mediated transport and upregulation of cysteine-type endopeptidase pathways in response to Eh. We conclude during Eh-macrophage outside-in signaling, ATG16L1 protein complex plays an overlooked regulatory role in shaping the pro-inflammatory landscape in amebiasis.

References

Jan 1, 1978·Transactions of the Royal Society of Tropical Medicine and Hygiene·L S DiamondC C Cunnick
Dec 1, 1989·Journal of Clinical Microbiology·S L ReedJ H McKerrow
Nov 1, 1987·The Journal of Clinical Investigation·W A PetriJ I Ravdin
Nov 1, 1987·The Journal of Clinical Investigation·K ChadeeJ I Ravdin
Dec 19, 1995·Proceedings of the National Academy of Sciences of the United States of America·R SéguinK Chadee
Apr 18, 2003·The New England Journal of Medicine·Rashidul HaqueWilliam A Petri
May 4, 2005·The Journal of Cell Biology·Masaaki KomatsuTomoki Chiba
Sep 2, 2005·Veterinary Immunology and Immunopathology·A Gruden-Movsesijan, Lj Sofronic Milosavljevic
Sep 4, 2007·Nature Reviews. Immunology·Beth Levine, Vojo Deretic
Feb 29, 2008·Nature·Noboru MizushimaDaniel J Klionsky
Mar 7, 2008·Molecular Biology of the Cell·Naonobu FujitaTamotsu Yoshimori
Oct 6, 2009·Current Topics in Microbiology and Immunology·Zhifen Yang, Daniel J Klionsky
Mar 13, 2010·The Journal of Pathology·Danielle GlickKay F Macleod
Nov 26, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hiroshi KobayashiMichael D Weiden
Dec 3, 2010·Nature·Rongbin ZhouJürg Tschopp
Jan 25, 2011·Journal of Proteome Research·Jürgen CoxMatthias Mann
Mar 12, 2011·The Journal of Clinical Investigation·Priya DuggalWilliam A Petri
Oct 25, 2011·Trends in Neurosciences·Rona K GrahamMichael R Hayden
Jun 21, 2012·Proceedings of the National Academy of Sciences of the United States of America·Caihong WangIndira U Mysorekar
Jan 30, 2013·The American Journal of Pathology·Vanessa Kissoon-SinghKris Chadee
Mar 26, 2013·Nature Immunology·Christopher LupferThirumala-Devi Kanneganti
Apr 3, 2013·Cold Spring Harbor Perspectives in Biology·David R McIlwainTak W Mak
Sep 26, 2013·Nature Reviews. Immunology·Vojo DereticShizuo Akira
Jan 21, 2014·Cell Death and Differentiation·X AoY Wu
Feb 1, 2014·Nature Methods·Michaela SpitzerMike Tyers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Caspases in Metabolic Diseases

Caspases, the family of cysteine proteases are involved in programmed cell death, but their role in metabolic diseases, inflammation and immunity has been of interested. Discover the latest research on caspases in metabolic diseases here.

Amoebiasis

Amoebiasis, infection by the protozoan parasite Entamoeba histolytica, remains a global health problem, despite the availability of effective treatment. Here is the latest research.